Category: Disorders & Diseases

Disorders & Diseases

NFID Initiative to Improve Respiratory Disease Prevention Messaging

The National Foundation for Infectious Diseases (NFID) launched an initiative to streamline evidence-based information regarding respiratory disease prevention.

Disorders & Diseases

New DNA Markers May Predict Lung Cancer Recurrence

Specific circular DNA features found in blood and tissue could help clinicians identify patients at high risk for recurrence after surgery.

Disorders & Diseases

Lung Cancer Survival Rates ‘Improving for Everyone,’ National Report Reveals

The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.

Chronic Pulmonary Disorders

COPD Foundation to Host Patient-Focused Drug Development Meeting

The COPD Foundation announced an upcoming meeting to ensure patient experiences and priorities are incorporated into the future of therapeutic development.

Infectious Diseases

Remdesivir Tied to Better Long-Term Health for Kidney Transplant Recipients With COVID-19

In kidney transplant recipients, early antiviral treatment with remdesivir reduced the risk of organ rejection and heart complications by nearly half for up to one year after diagnosis.

Critical Care

Reducing Unplanned Extubations in the ICU

A New Jersey hospital reversed an upward trend of unplanned extubation rates and maintained the improvement for five years.

Cardiopulmonary & Thoracic

Awareness of Lung Cancer Screening Availability Remains Low

Only one-third (33%) of surveyed Americans were aware that low-dose CT scans are available individuals at high-risk of lung cancer.

Sleep Medicine

FDA Approves Orzeyful for Narcolepsy Type 1

Orzeyful is the first drug to target the underlying loss of orexin signaling to address the full range of narcolepsy type 1.